Tscan Therapeutics Inc (TCRX)

07:03 AM

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference - GlobeNewswire

07:03 AM

07:00 AM

Cancer Therapy Pioneer TScan Therapeutics Set for Major Presentation at Jefferies Healthcare Conference - Stock Titan

07:00 AM

May 26, 2025

TScan Therapeutics’ SWOT analysis: biotech firm’s stock faces pivotal year By Investing.com - Investing.com Canada

May 26, 2025

May 26, 2025

TScan Therapeutics’ SWOT analysis: biotech firm’s stock faces pivotal year - Investing.com

May 26, 2025

May 23, 2025

New Data and Deal Flow Signal a Turning Point for Precision-Driv - GuruFocus

May 23, 2025

May 23, 2025

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs - Benzinga

May 23, 2025

May 22, 2025

Comparing TScan Therapeutics (NASDAQ:TCRX) and Twist Bioscience (NASDAQ:TWST) - Defense World

May 22, 2025

May 19, 2025

TScan Therapeutics, Inc. (NASDAQ:TCRX) Shares Bought by Cubist Systematic Strategies LLC - Defense World

May 19, 2025

May 17, 2025

Dimensional Fund Advisors LP Increases Stock Holdings in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

May 17, 2025

May 14, 2025

Stifel Financial Corp Acquires 10,567 Shares of TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

May 14, 2025

May 13, 2025

TScan Therapeutics, Inc. (NASDAQ:TCRX) Shares Bought by Barclays PLC - Defense World

May 13, 2025

May 12, 2025

H.C. Wainwright cuts Tscan stock target to $10, keeps Buy rating - Investing.com Nigeria

May 12, 2025

May 12, 2025

Equities Analysts Set Expectations for TCRX Q2 Earnings - Defense World

May 12, 2025

May 11, 2025

Research Analysts Set Expectations for TCRX FY2029 Earnings - Defense World

May 11, 2025

May 10, 2025

Wedbush Research Analysts Reduce Earnings Estimates for TCRX - Defense World

May 10, 2025

May 10, 2025

HC Wainwright Cuts TScan Therapeutics (NASDAQ:TCRX) Price Target to $10.00 - Defense World

May 10, 2025

May 09, 2025

TScan Therapeutics, Inc. (NASDAQ:TCRX) Position Trimmed by Renaissance Technologies LLC - Defense World

May 09, 2025

May 09, 2025

Brokers Offer Predictions for TCRX Q1 Earnings - Defense World

May 09, 2025

May 07, 2025

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 07, 2025

May 07, 2025

TScan Therapeutics (TCRX) Price Target Lowered by HC Wainwright | TCRX Stock News - GuruFocus

May 07, 2025

May 07, 2025

What Analysts Are Saying About TScan Therapeutics Stock - Benzinga

May 07, 2025

May 07, 2025

TScan Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 07, 2025

May 06, 2025

TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 06, 2025

May 06, 2025

TScan Therapeutics (TCRX) Exceeds Q1 Revenue Expectations | TCRX Stock News - GuruFocus

May 06, 2025

May 06, 2025

TScan Therapeutics Reveals Solid Progress: Key Clinical Data Coming in 2025, $251M War Chest Secured - Stock Titan

May 06, 2025

May 06, 2025

TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives $9.33 Average Target Price from Brokerages - Defense World

May 06, 2025

May 04, 2025

JPMorgan Chase & Co. Acquires 34,951 Shares of TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

May 04, 2025

Apr 30, 2025

BlackRock, Inc. Reduces Stake in TScan Therapeutics Inc by 43.05% - GuruFocus

Apr 30, 2025

Apr 29, 2025

Geode Capital Management LLC Has $2.93 Million Stock Position in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Apr 29, 2025

Apr 28, 2025

TScan Therapeutics Announces Abstract Acceptance for Poster Presentation at ASGCT 28th Annual Meeting - Nasdaq

Apr 28, 2025

Apr 28, 2025

TScan Therapeutics Announces Upcoming Presentation at the - GlobeNewswire

Apr 28, 2025

Apr 28, 2025

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting - Yahoo

Apr 28, 2025

Apr 22, 2025

What is the investor’s view on Tscan Therapeutics Inc (TCRX)? - uspostnews.com

Apr 22, 2025

Apr 17, 2025

Investing in Tscan Therapeutics Inc (TCRX) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - uspostnews.com

Apr 17, 2025

Apr 12, 2025

Prudential Financial Inc. Acquires Shares of 10,415 TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Apr 12, 2025

Apr 11, 2025

TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives $9.33 Average PT from Brokerages - Defense World

Apr 11, 2025

Apr 09, 2025

TScan Therapeutics’ (TCRX) “Buy” Rating Reaffirmed at Needham & Company LLC - Defense World

Apr 09, 2025

Apr 08, 2025

Tscan Therapeutics Inc (TCRX) deserves deeper analysis - uspostnews.com

Apr 08, 2025

Apr 08, 2025

Expert Outlook: TScan Therapeutics Through The Eyes Of 5 Analysts - Benzinga

Apr 08, 2025

Apr 01, 2025

Monitoring Gentherm Inc (THRM) after recent insider movements - knoxdaily.com

Apr 01, 2025

Apr 01, 2025

TScan Therapeutics, Inc. (NASDAQ:TCRX) Short Interest Update - Defense World

Apr 01, 2025

Mar 31, 2025

TScan Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 31, 2025

Mar 28, 2025

Tscan Therapeutics Inc [TCRX] Shares Fall Approximately -81.72% Over the Year - Knox Daily

Mar 28, 2025

Mar 27, 2025

TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access - Quantisnow

Mar 27, 2025

Mar 27, 2025

Cell Therapy Veteran With 16 Successful Launches Joins TScan Leadership - Stock Titan

Mar 27, 2025

Mar 17, 2025

TScan Therapeutics’ (TCRX) Overweight Rating Reiterated at Morgan Stanley - The AM Reporter

Mar 17, 2025

Mar 17, 2025

Analysts Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $9.33 - Defense World

Mar 17, 2025